跳至主要内容
临床试验/NCT07006090
NCT07006090招募中不适用

A Prospective, Observational, Post-Market Registry to Collect Real-World Clinical Data on the Use of the Histolog Scanner in Multiple Disease Areas.

SamanTree Medical SA1 个研究点 分布在 1 个国家目标入组 5,000 人开始时间: 2026年3月4日最近更新:
干预措施

试验速览

阶段
不适用
状态
招募中
入组人数
5,000
试验地点
1
主要终点
Number of confirmed medical interventions based on Histolog® image readings.

研究概览

简要总结

The goal of this observational study is to gather real-world evidence on the performance and safety of the Histolog® Scanner (HLS) when used as intended. HLS is a real-time ex-vivo tissue imaging device.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age ≥18 years old at the time of consenting
  • Undergoing a surgery or a medical procedure with use of Histolog® Scanner
  • Ability to understand and the willingness to sign a written informed consent.

排除标准

  • Active participation in a drug, device, or other medical intervention study that has not reached its primary endpoint at the time of consenting
  • Patients under judicial protection, legal guardianship or curatorship.

研究组 & 干预措施

Adult patients undergoing a surgery or a medical procedure with use of Histolog® Scanner

unique cohort in the study

干预措施: Histolog Scanner (Device)

结局指标

主要结局

Number of confirmed medical interventions based on Histolog® image readings.

时间窗: From enrolment to diagnosis confirmation at post surgery follow-up visit (V2: 37 days after enrolment)

次要结局

  • Concordance between the assessment of Histolog® images and the final pathology assessment expressed as sensitivity, specificity, positive predictive value, and negative predictive value(From enrolment to post surgery follow-up visit (V2: 37 days after enrolment))
  • Re-operation rates if Histolog® used for intra-operative assessment(From surgery (V1: Day 0) to post surgery follow-up visit (V2: +30 days))
  • Cancer-free survival up to 5 years of follow-up(From enrolment to the end of 5 years follow-up)
  • Evaluation of usage patterns across different indications and application profiles.(From enrolment to the end of 5 years follow-up.)
  • Device deficiency defined as any inadequacy in the identity, quality, durability, reliability, safety or performance of a device, including malfunction, use errors or inadequacy in information supplied by the manufacturer.(From first patient surgery visit (V1: Day 0) to last patient surgery visit.)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验